In his new role, Shisher will lead Glenmark’s marketing initiatives, focusing on strengthening brand positioning, driving market expansion, and accelerating growth
The bonds, due June 15, 2030, were placed with Swiss investors under the joint lead of UBS and Zürcher Kantonalbank
Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.
India already has talent, digital infrastructure, entrepreneurial energy, clinical expertise, and policy momentum. The next phase demands coordinated execution and building institutions that can hold the ecosystem together over time
AAV vectors are widely used in gene therapy for their strong therapeutic potential
The new CRS offering is delivered from WACKER’s Biotechnology Center in Munich
The event is expected to attract more than 100 senior professionals from pharmaceutical companies, CROs, regulatory agencies, and technology organisations
BMS is moving beyond conversational AI into what it describes as “agentic” systems
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
Deployment aims to improve serialization efficiency by 45% and enhance regulatory compliance across global export markets
Subscribe To Our Newsletter & Stay Updated
